Search

Your search keyword '"BÜYÜKÇAM, AYŞE"' showing total 4 results
Start Over Author "BÜYÜKÇAM, AYŞE" Topic sars-cov-2
4 results on '"BÜYÜKÇAM, AYŞE"'

1. A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey.

Author

Yılmaz, Dilek, Üstündağ, Gülnihan, Büyükçam, Ayşe, Salı, Enes, Çelik, Ümit, Avcu, Gülhadiye, Belet, Nurşen, Çakmak Taşkın, Esra, Öcal Demir, Sevliya, Birbilen, Ahmet Ziya, Kılıç, Ömer, Metin Akcan, Özge, Tekin Yılmaz, Ayşe, Aldemir Kocabaş, Bilge, Hatipoğlu, Nevin, Karbuz, Adem, Çakır, Deniz, Sütçü, Murat, Aygün, Fatma Deniz, and Çelik, Taylan

Subjects
SARS-CoV-2, COUGH, COVID-19, VACCINATION
Abstract

This multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs. What is Known: • Children with COVID-19 mainly present with fever and cough, as in adults. • COVID-19 may specifically threaten children with underlying chronic diseases. What is New: • Children with obesity have a higher vaccination rate against COVID-19 than children without obesity. • Among unvaccinated children, fever and pneumoniae might be seen at a higher ratio than among vaccinated children. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

2. SARS-CoV-2 seropositivity among pediatric health care personnel just after the first peak of pandemic: A nationwide surveillance

Author

Gürlevik, Sibel Laçinel, Kaba, Özge, Aktürk, Hacer, Erkum, İlyas Tolga, Turgut, Mehmet, Demirbuğa, Asuman, Keleş, Yıldız Ekemen, Yazıcıoğlu, Bahadır, Hacımustafaoğlu, Mustafa, Dinleyici, Ener Çağrı, Erat, Tuğba, Emiroğlu, Melike, Üstün, Tuğba, Kara, Soner Sertan, Doğan, Hazal Helin, Erdeniz, Emine Hafize, İşançlı, Didem Kızmaz, Yanartaş, Mehpare Sarı, Efe, Kadir, Çetin, Ceren, Dalgıç, Nazan, Büyükçam, Ayşe, Oygar, Pembe Derin, Yaşar, Belma, Ovalı, Hüsnü Fahri, Özçelik, Taha, Bilen, Melis, Bal, Zümrüt Şahbudak, Kukul, Musa Gürel, Özkınay, Ferda, Küçükalioğlu, Burcu Parıltan, Gül, Doruk, Avcu, Gülhadiye, Bozdemir, Şefika Elmas, Yenidoğan, İrem, Alkan, Gülsüm, Çiftçi, Diclehan, Şen, Semra, Kılıç, Ömer, Karbuz, Adem, Güner, Gizem, Yeşil, Edanur, Tezer, Hasan, Salı, Enes, Karasulu, Burcugül, Atikan, Başak Yıldız, Turan, Cansu, Akkoç, Gülşen, Demir, Sevliya Öcal, Oğuz, Şerife Bahtiyar, Çelebi, Solmaz, Özer, Arife, Yahşi, Aysun, Kara, Tuğçe Tural, Çiftdoğan, Dilek Yılmaz, Okur, Dicle Şener, Törün, Selda Hançerli, Akkuş, Gökhan, Hatipoğlu, Sadık Sami, Sarı, Emine Ergül, Arslanoğlu, Sertaç, Şahin, Aslıhan, Öz, Şadiye Kübra Tüter, Çelebi, Emel, Aydın, Zeynep Gökçe Gayretli, Hatipoğlu, Halil, Sütçü, Murat, Durmuş, Habibe Selver, Tekeli, Seher, Karaaslan, Ayşe, Bülbül, Lida, Almış, Habip, Cebeci, Sinem Oral, Akın, Yasemin, Kurugöl, Zafer, Aygün, Fatma Deniz, Kara, Ateş, Somer, Ayper, Cengiz, Ali Bülent, Uygun, Hatice, Çoban, Rabia, Elevli, Murat, Çakır, Deniz, Hatipoğlu, Nevin, Kara, Yalçın, Bucak, Ibrahim Hakan, and Çetin, BENHUR ŞİRVAN

Subjects
COVID-1, personnel protective equipment use, Turkey, SARS-CoV-2, Health Personnel, serology, COVID-19, Antibodies, Viral, Article, Seroepidemiologic Studies, Humans, Child, Delivery of Health Care, Pandemics, SARS Co-V-2, healthcare personnel
Abstract

Understanding SARS-CoV-2 seroprevalence among health care personnel is important to explore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future.We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed.SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19.Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission.

Published
2021

3. SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey.

Author

Oygar, Pembe Derin, Büyükçam, Ayşe, Bal, Zümrüt Şahbudak, Dalgıç, Nazan, Bozdemir, Şefika Elmas, Karbuz, Adem, Çetin, Benhur Şirvan, Kara, Yalçın, Çetin, Ceren, Hatipoğlu, Nevin, Uygun, Hatice, Aygün, Fatma Deniz, Törün, Selda Hançerli, Okur, Dicle Şener, Çiftdoğan, Dilek Yılmaz, Kara, Tuğçe Tural, Yahşi, Aysun, Özer, Arife, Demir, Sevliya Öcal, and Akkoç, Gülşen

Subjects
*MEDICAL personnel, *SARS-CoV-2, *PEDIATRIC therapy, *SEROCONVERSION, *COVID-19 pandemic
Abstract

• The seropositivity for SARS-CoV-2 is found to be 6.1% among healthcare personnel • Most of them were healthy young adults • Surveillance for healthcare personnel should involve routine nucleic acid testing • Monitoring personal protective equipment adherence is vital for COVID-19 protection Understanding SARS-CoV-2 seroprevalence among health care personnel is important to explore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future. We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed. SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19. Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

4. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group

Author

Dilek Yilmaz Ciftdogan, Yildiz Ekemen Keles, Benhur Sirvan Cetin, Nazan Dalgic Karabulut, Melike Emiroglu, Zafer Bagci, Ayse Buyukcam, Emine Hafize Erdeniz, Gul Arga, Edanur Yesil, Ozlem Cakici, Adem Karbuz, Zumrut Sahbudak Bal, Soner Sertan Kara, Arife Ozer, Ozge Metin Akcan, Sefika Elmas Bozdemir, Ayse Berna Anil, Hatice Uygun, Omer Kilic, Selda Hancerli Torun, Zuhal Umit, Murat Sutcu, Berfin Ozgokce Ozmen, Hatice Karaoglu Asrak, Gulsum Alkan, Ahu Kara Aksay, Cuneyt Ugur, Ahmet Ziya Birbilen, Burcu Bursal Duramaz, Esra Akyuz Ozkan, Ozgur Burakay, Sema Yildirim Arslan, Eda Karadag Oncel, Serkan Fazli Celik, Ahmet Osman Kilic, Seval Ozen, Remzi Sarikaya, Demet Demirkol, Gazi Arslan, Ozden Turel, Ahmet Sert, Ergul Sari, Zerrin Orbak, Irfan Oguz Sahin, Celal Varan, Hacer Akturk, Sadiye Kubra Tuter Oz, Fatih Durak, Mehmet Burhan Oflaz, Manolya Kara, Derya Karpuz, Mey Talip Petmezci, Nevin Hatipoglu, Selim Oncel, Mehmet Turgut, Ferhan Elmali, Ayper Somer, Necdet Kuyucu, Ener Cagri Dinleyici, Zafer Kurugöl, Ergin Ciftci, Ates Kara, BURSAL DURAMAZ, BURCU, TÜREL, ÖZDEN, Aktürk, Hacer, Çiftdoğan, Dilek Yılmaz, Keleş, Yıldız Ekemen, Çetin, Benhur Şirvan, Karabulut, Nazan Dalgıç, Emiroğlu, Melike, Bağcı, Zafer, Büyükçam, Ayşe, Erdeniz, Emine Hafize, Arga, Gül, Yeşil, Edanur, Çakıcı, Özlem, Karbuz, Adem, Bal, Zümrüt Şahbudak, Kara, Soner Sertan, Özer, Arife, Akcan, Özge Metin, Bozdemir, Şefika Elmas, Anıl, Ayşe Berna, Uygun, Hatice, Kılıç, Ömer, Torun, Selda Hancerli, Ümit, Zuhal, Sütcü, Murat, Özmen, Berfin ÖzgÖkce, Asrak, Hatice Karaoğlu, Alkan, Gülsüm, Aksay, Ahu Kara, Uğur, Cüneyt, Birbilen, Ahmet Ziya, Duramaz, Burcu Bursal, Özkan, Esra Akyüz, Burakay, Özgür, Arslan, Sema Yıldırım, Öncel, Eda Karadağ, Celik, Serkan Fazlı, Kılıç, Ahmet Osman, Özen, Seval, Sarıkaya, Remzi, Demirkol, Demet, Arslan, Gazi, Türel, Özden, Sert, Ahmet, Sarı, Ergül, Orbak, Zerrin, Şahin, İrfan Oğuz, Varan, Celal, Öz, Sadiye Kübra Tuter, Durak, Fatih, Oflaz, Mehmet Burhan, Kara, Manolya, Karpuz, Derya, Petmezci, Mey Talip, Hatipoğlu, Nevin, Öncel, Selim, Turgut, Mehmet, Elmalı, Ferhan, Somer, Ayper, Kuyucu, Necdet, Dinleyici, Ener Cağrı, Kurugöl, Zafer, Çiftci, Ergin, Kara, Ateş, Koç University Hospital, İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Murat Sütçü / 0000-0002-2078-9796, Manolya Kara / 0000-0001-6234-7024, Sütçü, Murat, Murat Sütçü / AAR-5212-2020, Manolya Kara / AGI-2212-2022, Murat Sütçü / 55499199300, and Manolya Kara / 57213122996

Subjects
Lethargy, Kawasaki disease, SARS-CoV-2, COVID-19, MIS-C, Mucocutaneous Lymph Node Syndrome, Pediatrics, Systemic Inflammatory Response Syndrome, Children, Child, Preschool, Pediatrics, Perinatology and Child Health, Humans, Original Article, Child, Procalcitonin, Retrospective Studies
Abstract

Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This study is a retrospective analysis of a case series designed for patients aged 1 month to 18 years in 28 hospitals between November 1, 2020, and June 9, 2021. Patient demographics, complaints, laboratory results, echocardiographic results, system involvement, and outcomes were recorded. A total of 614 patients were enrolled; the median age was 7.4 years (interquartile range (IQR) 3.9-12 years). A total of 277 (45.1%) patients with MIS-C had manifestations that overlapped with KD, including 92 (33.3%) patients with complete KD and 185 (66.7%) with incomplete KD. Lymphocyte and platelet counts were significantly lower in patients with MISC, overlapped with KD (lymphocyte count 1080 vs. 1280 cells x mu L, p = 0.028; platelet count 166 vs. 216 cells x 10(3)/mu L, p < 0.001). The median serum procalcitonin levels were statistically higher in patients overlapped with KD (3.18 vs. 1.68 mu g/L, p = 0.001). Coronary artery dilatation was statistically significant in patients with overlap with KD (13.4% vs. 6.8%, p = 0.007), while myocarditis was significantly more common in patients without overlap with KD features (2.6% vs 7.4%, p = 0.009). The association between clinical and laboratory findings and overlap with KD was investigated. Age > 12 years reduced the risk of overlap with KD by 66% (p < 0.001, 95% CI 0.217-0.550), lethargy increased the risk of overlap with KD by 2.6-fold (p = 0.011, 95% CI 1.244-5.439), and each unit more albumin (g/dl) reduced the risk of overlap with KD by 60% (p < 0.001, 95% CI 0.298-0.559). Conclusion: Almost half of the patients with MISC had clinical features that overlapped with KD; in particular, incomplete KD was present. The median age was lower in patients with KD-like features. Lymphocyte and platelet counts were lower, and ferritin and procalcitonin levels were significantly higher in patients with overlap with KD., NA

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results